EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey
about
Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyMolecular Testing of Lung CancersA multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).Integrated digital error suppression for improved detection of circulating tumor DNAAnalysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey.EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations.EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status.A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.Detection of EGFR and KRAS gene mutations using suspension liquid-based cytology specimens in metastatic lung adenocarcinoma.Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan.Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test.EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer.Value of (18)F-FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients.Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern.Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer.Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients.Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational studyHistology versus cytology: PD-L1 testing in non-small cell lung cancerReal-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
P2860
Q26744284-E3AF1819-8A22-45EF-BF25-F4BF255B158DQ33729715-58D2AE02-2AF7-4743-8F7D-1E3E296201F0Q33868401-7C717F7B-98EB-4375-82E7-E2A2143E7023Q34520008-0BFC0DB5-540E-443E-AFEE-0E252731C880Q36417758-3595141A-F635-453D-AEB4-D24151E6493FQ38373208-5337CF18-2B03-45FA-8FAF-C41CF81EE42EQ38767492-75319B2D-6A90-4CA3-B196-57FF6BFA0F45Q38924458-76A72F03-18DE-47DE-8ED7-149CCFF7055EQ39651867-AEAC0830-3767-440A-A02C-AD114B8AB049Q40502030-106676F1-072A-4E39-86AC-B79C627199AFQ41437605-9B34D701-659B-4E43-9014-3EF9E6C3D7A7Q42290335-AD85EBD1-7550-4148-98C1-A4C9657E3B4AQ47104483-1570355C-13A6-4F2F-8167-4446A9C8A18BQ47112441-EBC25500-9F8B-4052-A0A1-3275CF5F55E5Q47151343-4DDE823C-FA5A-495C-99F7-237B483B4F8AQ47214499-E7EB71EA-0072-449A-8809-528509B170D0Q47574237-2BBCE7A0-9BF6-4222-8DC5-C2F6EA298475Q47579692-0C75FCD8-6735-4BF0-8FEB-130658101B3DQ47654942-DF10B8E7-74C0-488F-841B-EC2AD0DB37DCQ49746232-560ADC61-95C1-4D33-8942-3FD38D0E78C6Q52332839-23D50F98-71A1-48B5-A9D8-43657546D8A5Q55515297-31628B18-E0F7-4C63-BBF0-FA696B3D423FQ57213617-2BA578E2-F22D-417A-B063-9A58E216E18AQ58562455-3EBA5AEA-02C2-4BAA-9853-8CE4016F6B2AQ59137536-445C9EBD-6AAC-4EF9-943F-2854C190FE77
P2860
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
EGFR mutation testing practice ...... multicenter diagnostic survey
@ast
EGFR mutation testing practice ...... multicenter diagnostic survey
@en
type
label
EGFR mutation testing practice ...... multicenter diagnostic survey
@ast
EGFR mutation testing practice ...... multicenter diagnostic survey
@en
prefLabel
EGFR mutation testing practice ...... multicenter diagnostic survey
@ast
EGFR mutation testing practice ...... multicenter diagnostic survey
@en
P2093
P2860
P50
P1476
EGFR mutation testing practice ...... multicenter diagnostic survey
@en
P2093
Chun-Ming Tsai
Geon Kook Lee
Jabed Iqbal
Jin-Haeng Chung
Keith M Kerr
Keunchil Park
Koichi Hagiwara
Ma Luisa D Enriquez
Marianne Ratcliffe
P2860
P304
P356
10.1097/JTO.0000000000000422
P577
2015-03-01T00:00:00Z